loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 209862 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 NALOXONE HYDROCHLORIDE (1)

filter

01 KALEO INC (1)

filter

01 SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS (1)

filter

01 2MG/0.4ML (2MG/0.4ML) (1)

filter

01 USA (1)

URL Supplier Web Content
SOLUTION;INTRAMUSCULAR...
2MG/0.4ML (2MG/0.4ML)
EVZIO (AUTOINJECTOR)
USA
209862
2016-10-19
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 209862

Looking for CTD TGA MCC DOSSIER APPLICATION 209862 1

19

KALEO INC, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is NALOXONE HYDROCHLORIDE, with a corresponding application number 209862 and regulatory information .

proudly manufactured in the

approval since 2016-10-19

KALEO INC's EVZIO (AUTOINJECTOR) SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS, medication with 2MG/0.4ML (2MG/0.4ML) of NALOXONE HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY